You have 9 free searches left this month | for more free features.

Methicillin-susceptible Staphylococcus aureus (MSSA)

Showing 1 - 25 of 1,620

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus Trial in Paris (Cloxacillin, Cefazolin)

Recruiting
  • Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus
  • Paris, France
    François-Xavier Lescure
Dec 7, 2022

Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Staphylococcal Sepsis Trial in Montreal (Ertapenem, Placebo)

Not yet recruiting
  • Staphylococcus Aureus Bacteremia
  • +3 more
  • Montreal, Quebec, Canada
    McGill University Health Centre (Royal Victoria Hospital and Mon
Feb 21, 2022

Antistaphylococcal Betalactam and Emergence of Resistance

Completed
  • Bacterial Resistance
  • Methicillin-Sensitive Staphylococcus Aureus Infection
    • Nancy, Lorraine, France
      Lefevre
    Jul 1, 2023

    Bacteremia Due to Staphylococcus Aureus, Left Sided Infective Endocarditis (Disorder), Right Sided Infective Endocarditis

    Withdrawn
    • Bacteremia Due to Staphylococcus Aureus
    • +3 more
    • Tonabacase (LSVT-1701)
    • Butte, Montana
      Lsvt-1701-2001
    Jun 27, 2022

    Initial and Chronic Methicillin Resistant Staphylococcus Aureus

    Completed
    • Methicillin-Resistant Staphylococcus Aureus
    • Cystic Fibrosis
    • Intervention N/A. Observational study
    • Birmingham, Alabama
    • +2 more
    Jan 19, 2022

    Hemodialysis Catheter Infection, Infection, Bacterial Trial in Orléans, Tours (Blood samples)

    Not yet recruiting
    • Hemodialysis Catheter Infection
    • Infection, Bacterial
    • Blood samples
    • Orléans, France
    • +1 more
    Oct 16, 2023

    Staphylococcus Aureus Bacteremia Trial in Worldwide (Cefazolin, Penicillin, Clindamycin)

    Recruiting
    • Staphylococcus Aureus Bacteremia
    • Garran, Australia Capital Territory, Australia
    • +73 more
    Feb 23, 2022

    Methicillin Susceptible Staphylococcus Aureus Septicemia, Bacteremia Trial in Montreal (Daptomycin, Placebo)

    Completed
    • Methicillin Susceptible Staphylococcus Aureus Septicemia
    • Bacteremia
    • Montreal, Quebec, Canada
      McGill University Health Centre (Royal Victoria Hospital, Montre
    Sep 18, 2020

    Diabetic Foot, Staphylococcal Infections Trial in France (Topical anti-Staphylococcus bacteriophage therapy, Topical

    Not yet recruiting
    • Diabetic Foot
    • Staphylococcal Infections
    • Topical anti-Staphylococcus bacteriophage therapy
    • Topical placebo corresponding to anti-Staphylococcus bacteriophage therapy
    • Bordeaux, France
    • +8 more
    Feb 2, 2022

    MRSA Bloodstream Infection, MRSA Bacteremia, MRSA Right-sided Endocarditis Trial in Butte, Toledo (Exebacase)

    No longer available
    • MRSA Bloodstream Infection
    • +3 more
    • Butte, Montana
    • +1 more
    Aug 25, 2022

    Methicillin-Resistant Staphylococcus Aureus, Bacterial Infections, Staphylococcal Skin Infections Trial in Worldwide

    Recruiting
    • Methicillin-Resistant Staphylococcus Aureus
    • +2 more
    • Dalbavancin single dose
    • +2 more
    • Mobile, Alabama
    • +26 more
    Jan 27, 2023

    Probability of Target Attainment With Standard Intermittent

    Completed
    • Staphylococcus Aureus Infection
    • Blood samples for the measurement of the concentration of cefazolin
    • +4 more
    • Basel, Switzerland
      University Hospital Basel, Division of Internal Medicine
    Mar 28, 2022

    Methicillin-resistant Staphylococcus Aureus Infection Trial in Falls Church, Leesburg (Preoperative MRSA screening)

    Terminated
    • Methicillin-resistant Staphylococcus Aureus Infection
    • Preoperative MRSA screening
    • Falls Church, Virginia
    • +1 more
    Jun 3, 2021

    Infection Control to Knee Periprosthetic Joint Infection -United

    Recruiting
    • Knee; Infection, Joint
    • Two-stage exchange arthroplasty
    • Taoyuan, Taiwan
      Department of Orthopedic Surgery at Linkou Changgung Memorial Ho
    Sep 11, 2023

    Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, Pseudomonas Aeruginosa Trial in Philadelphia (PMT)

    Not yet recruiting
    • Multidrug Resistant Bacterial Infection
    • +4 more
    • Philadelphia, Pennsylvania
      Hospital of the University of Pennsylvania
    Nov 17, 2022

    Antibiotic Prophylaxis, General Surgery Trial in Marseille (Vancomycin Injection, Linezolid Injection)

    Not yet recruiting
    • Antibiotic Prophylaxis
    • General Surgery
    • Vancomycin Injection
    • Linezolid Injection
    • Marseille, France
      Anesthésie Réanimation - Hôpital Nord (AP-HM)
    Oct 5, 2022

    Staphylococcus Aureus, Carbapenem Resistant Gram Negative Bacteria Trial (Targeted gown and gloves use)

    Not yet recruiting
    • Staphylococcus Aureus
    • Carbapenem Resistant Gram Negative Bacteria
    • Targeted gown and gloves use
    • (no location specified)
    Oct 26, 2021

    Emergencies Trial (GeneXpert®)

    Withdrawn
    • Emergencies
    • GeneXpert®
    • (no location specified)
    Nov 9, 2020

    Healthy Volunteers, Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus Aureus Trial in Seoul (N-Rephasin® SAL200,

    Completed
    • Healthy Volunteers
    • +3 more
    • N-Rephasin® SAL200
    • INT200-Placebo
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Oct 26, 2021

    Risk Factors for Multidrug Resistant Bacteria at ICU Admission

    Not yet recruiting
    • Multi Drug Resistant Bacteria
    • Identification o Multi Drug Resistant Bacteria
    • (no location specified)
    Aug 2, 2023

    CA-MRSA Transmission: An ED Population Sampling Strategy

    Recruiting
    • Methicillin-Resistant Staphylococcus Aureus
    • Acute Abscess Group
    • Gainesville, Florida
      UF Health
    Jun 4, 2021

    Staphylococcus Aureus Bacteremia, Anti-Bacterial Agents Trial in Seongnam-si, Seoul (N-Rephasin® SAL200, Placebo)

    Terminated
    • Staphylococcus Aureus Bacteremia
    • Anti-Bacterial Agents
    • N-Rephasin® SAL200
    • Placebo
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
    • +1 more
    Sep 12, 2021

    Cystic Fibrosis, Methicillin-resistant Staphylococcus Aureus Trial in Cleveland (Vancomycin)

    Withdrawn
    • Cystic Fibrosis
    • Methicillin-resistant Staphylococcus Aureus
    • Cleveland, Ohio
      Rainbow Babies and Children's Hospital, Univeristy Hospitals Cas
    Dec 23, 2021

    PJI, Bone and Joint Infection, Pharmacokinetics Trial (sampling blood, Sampling synovial fluid, Sampling bone tissue)

    Not yet recruiting
    • PJI
    • +2 more
    • sampling blood
    • +2 more
    • (no location specified)
    Jun 13, 2022

    Bone or Joint Infection Trial in Ukraine, United States (Afabicin (Part A), Standard of Care, Afabicin (Part B))

    Recruiting
    • Bone or Joint Infection
    • Afabicin (Part A)
    • +2 more
    • Sacramento, California
    • +13 more
    Sep 29, 2022